Background: Hepatitis C is endemic in most parts of the world. It is a blood borne infection, which has a significant impact in treatment and outcome of renal failure patients undergoing dialysis.
Objective:To determine the seroprevalence of hepatitis C in renal failure patients on maintenance hemodialysis in a tertiary care hospital.
Materials and Methods:This study was carried out retrospectively on patients undergoing hemodialysis whose samples were received for Hepatitis C screening in the A total of 910 patients were included in the study conducted over a period of 12 months. Screening for anti-hepatitis C virus (HCV) antibodies was done by a third-generation enzyme-linked immunosorbent assay and their epidemiological data were analyzed.
Result:Of the 910 patients screened for anti-HCV antibodies, 25 patients were found to be positive for Hepatitis C. The overall seroprevalence of hepatitis C among dialysis patients was 2.7%. The HCV positive rates were more among the males and highest in the age group of 30-60 years. Only 44% seropositive patient had raised alanine transaminase level.Conclusion: Regular screening of hepatitis C patients is mandatory as it has a detrimental effect contributing to morbidity and mortality. Strict adherence to infection control practices should be prioritized in the health-care settings to reduce the burden of disease among the high-risk groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.